EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation

Jeremy A Bartlett iD, Natalie Culver, Matt Santangelo, Andrew Prpich, Erica Long, Kazuko Sagawa iD, Ravi Shanker, Huiping Xu, Keith Wilner iD

Pharmaceutical Medicine · 2026-05 · 40 (3) · 193-207

DOI: 10.1007/s40290-026-00604-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Medicine, online erschienen am 01.04.2026. Verfasst von Jeremy A Bartlett und 8 weiteren Autor:innen. Beteiligte Einrichtung: Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA. jeremy.a.bartlett@pfizer.com. Hauptthemen laut MEDLINE: Antineoplastic Agents, Crizotinib, Protein Kinase Inhibitors, Taste. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCrizotinibProtein Kinase InhibitorsTasteAdolescentAdultChildChild, PreschoolFemaleHumansMaleYoung AdultAdministration, OralChemistry, PharmaceuticalDosage FormsDrug CompoundingMicrospheresTherapeutic EquivalencyClinical Trials as Topic

Substanzen

Antineoplastic AgentsCrizotinibDosage FormsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA. jeremy.a.bartlett@pfizer.com.
  • Global Research and Development, Pharmaceutical Sciences, Pfizer Inc., Groton, CT, USA.
  • Global Research and Development, Clinical Pharmacology, Pfizer Inc., San Diego, CA, USA.
  • Global Research and Development, Clinical, Pfizer Inc., San Diego, CA, USA.

ORCID-Profile: Jeremy A Bartlett, Kazuko Sagawa, Keith Wilner

Förderung

  • Pfizer

Zitieren

APA

Bartlett, J. A., Culver, N., Santangelo, M., Prpich, A., Long, E., Sagawa, K., Shanker, R., Xu, H., & Wilner, K. (2026). Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation. Pharmaceutical Medicine, 40(3), 193-207. https://doi.org/10.1007/s40290-026-00604-2

Vancouver

Bartlett JA, Culver N, Santangelo M, Prpich A, Long E, Sagawa K, et al. Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation. Pharmaceutical Medicine. 2026;40(3):193-207. doi:10.1007/s40290-026-00604-2

BibTeX
@article{Bartlett2026,
  author = {Bartlett, Jeremy A and Culver, Natalie and Santangelo, Matt and Prpich, Andrew and Long, Erica and Sagawa, Kazuko and Shanker, Ravi and Xu, Huiping and Wilner, Keith},
  title = {Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation},
  journal = {Pharmaceutical Medicine},
  year = {2026},
  volume = {40},
  number = {3},
  pages = {193--207},
  doi = {10.1007/s40290-026-00604-2}
}
Kostenlos starten →